Skip to main content
Livermore
Livermore
ZHEN

TCR2 Therapeutics Inc.

TCRRDelisted Jun 1, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001750019

TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in TCR2 Therapeutics Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

TCRR is no longer listed, and 13F filings after Q1 2023 list far fewer holders. See Q1 2023

Institutional holders
0
−59 vs. Q1 2023
Shares held
0
−21.0M (−100.0%) vs. Q1 2023
Total value
$0
−$31.5M (−100.0%) vs. Q1 2023
New holders
0
0 more added
Sold out
59
0 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 0 institutions
Q1 2021: 129 institutionsQ2 2021: 119 institutionsQ3 2021: 117 institutionsQ4 2021: 122 institutionsQ1 2022: 94 institutionsQ2 2022: 83 institutionsQ3 2022: 81 institutionsQ4 2022: 63 institutionsQ1 2023: 59 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $0
Q1 2021: $834.8MQ2 2021: $575.3MQ3 2021: $271.1MQ4 2021: $136.0MQ1 2022: $74.8MQ2 2022: $72.2MQ3 2022: $45.1MQ4 2022: $21.2MQ1 2023: $31.5MQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TCRR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 202359$31.5M
Q4 202263$21.2M
Q3 202281$45.1M
Q2 202283$72.2M
Q1 202294$74.8M
Q4 2021122$136.0M
Q3 2021117$271.1M
Q2 2021119$575.3M
Q1 2021129$834.8M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q1 2023.

Institutions holding TCRR in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
MPM Asset Management LLC0$00.00%−4,050,865−100.0%Sold out
Tang Capital Management LLC0$00.00%−3,399,745−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−3,370,982−100.0%Sold out
Vanguard Group Inc0$00.00%−1,468,802−100.0%Sold out
Newtyn Management, LLC0$00.00%−1,015,920−100.0%Sold out
Acadian Asset Management LLC0$00.00%−812,459−100.0%Sold out
BlackRock Inc.0$00.00%−789,911−100.0%Sold out
Baker Bros. Advisors LP0$00.00%−753,064−100.0%Sold out
Artal Group S.A.0$00.00%−750,000−100.0%Sold out
Redmile Group, LLC0$00.00%−658,336−100.0%Sold out
Long Focus Capital Management, LLC0$00.00%−566,270−100.0%Sold out
JPMorgan Chase & Co0$00.00%−524,184−100.0%Sold out
Renaissance Technologies LLC0$00.00%−444,800−100.0%Sold out
Citigroup Inc0$00.00%−383,486−100.0%Sold out
Geode Capital Management, LLC0$00.00%−315,377−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−181,810−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−171,214−100.0%Sold out
Morgan Stanley0$00.00%−155,390−100.0%Sold out
State Street Corp0$00.00%−137,219−100.0%Sold out
FMR LLC0$00.00%−120,633−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−111,000−100.0%Sold out
Northern Trust Corp0$00.00%−93,933−100.0%Sold out
Cornercap Investment Counsel Inc0$00.00%−71,046−100.0%Sold out
Harbor Capital Advisors, Inc.0$00.00%−67,642−100.0%Sold out
Ergoteles LLC0$00.00%−57,279−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−48,900−100.0%Sold out
Sagefield Capital LP0$00.00%−43,900−100.0%Sold out
Wells Fargo & Company0$00.00%−40,688−100.0%Sold out
Oppenheimer & Co Inc0$00.00%−37,950−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−37,452−100.0%Sold out
Two Sigma Investments, LP0$00.00%−36,000−100.0%Sold out
Barclays PLC0$00.00%−33,116−100.0%Sold out
Millennium Management LLC0$00.00%−31,683−100.0%Sold out
X-Square Capital, LLC0$00.00%−31,720−100.0%Sold out
Commonwealth Equity Services, LLC0$00.00%−24,973−100.0%Sold out
Charles Schwab Investment Management Inc0$00.00%−22,638−100.0%Sold out
Bank of America Corp0$00.00%−21,166−100.0%Sold out
HSBC Holdings PLC0$00.00%−17,257−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−12,755−100.0%Sold out
Newman Dignan & Sheerar, Inc.0$00.00%−12,522−100.0%Sold out
Independent Financial Group, LLC0$00.00%−12,075−100.0%Sold out
Goldman Sachs Group Inc0$00.00%−10,765−100.0%Sold out
HRT Financial LP0$00.00%−11,024−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−7,678−100.0%Sold out
Federated Hermes, Inc.0$00.00%−7,081−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−3,050−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−1,801−100.0%Sold out
Simplex Trading, LLC0$00.00%−1,444−100.0%Sold out
HighMark Wealth Management LLC0$00.00%−840−100.0%Sold out
Group One Trading, L.P.0$00.00%−800−100.0%Sold out
US Bancorp0$00.00%−700−100.0%Sold out
Cutler Group LP0$00.00%−1,000−100.0%Sold out
Federation des caisses Desjardins du Quebec0$00.00%−500−100.0%Sold out
UBS Group AG0$00.00%−234−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−140−100.0%Sold out
Beaird Harris Wealth Management, LLC0$00.00%−61−100.0%Sold out
Salem Investment Counselors Inc0$00.00%−35−100.0%Sold out
Investors Research Corp0$00.00%−15−100.0%Sold out
Royal Bank of Canada0$00.00%−85−100.0%Sold out